Table 4 Mean (SD) 2FA binding (VT/fp) within the AD and MCI groups, for those on and off AChEI medication
Variable | MCI | AD | ||
|---|---|---|---|---|
Off aAChEI (n = 20) | Ona AChEI (n = 8) | Off AChEI (n = 9) | On AChEI (n = 23) | |
L thalamus | 12.25 (1.76) | 11.91 (2.50) | 12.96 (1.57)b | 10.94 (1.98) |
R thalamus | 12.42 (1.64) | 12.28 (2.62) | 13.12 (1.53)b | 11.17 (2.34) |
L hippocampus | 7.15 (.83) | 7.63 (1.20) | 7.50 (.84)b | 5.88 (1.19) |
R hippocampus | 7.18 (.80) | 7.44 (1.30) | 7.34 (.82)b | 6.14 (.93) |
L caudate | 5.92 (1.62) | 5.16 (2.28) | 5.40 (1.85) | 4.46 (1.91) |
R caudate | 6.15 (1.52) | 5.50 (1.39) | 5.90 (1.64) | 4.31 (2.11) |
L entorhinal | 8.55 (1.22) | 8.51 (1.28) | 8.51 (.87) | 8.48 (1.77) |
R entorhinal | 10.21 (1.35) | 10.51 (2.01) | 10.13 (1.11) | 9.67 (2.48) |
L insula | 8.22 (.95) | 8.93 (1.01) | 8.67 (1.16) | 7.87 (1.39) |
R insula | 8.44 (.80) | 8.95 (1.07) | 8.72 (1.38) | 8.00 (1.05) |
L anterior cingulate | 10.17 (1.20) | 10.63 (1.76) | 10.71 (1.43) | 10.15 (1.93) |
R anterior cingulate | 10.22 (1.15) | 10.47 (1.55) | 10.70 (1.43) | 9.68 (2.22) |